- Report
- December 2023
- 261 Pages
Global
From €4769EUR$5,423USD£3,950GBP
The Biologic API Contract Manufacturer market is a specialized segment of the biopharmaceutical industry that focuses on the production of active pharmaceutical ingredients (APIs) for biologic drugs. These APIs are complex molecules derived from living organisms, such as proteins, peptides, and antibodies. Contract manufacturers provide a range of services, including process development, scale-up, and commercial manufacturing. They also provide quality control and regulatory support to ensure that the APIs meet the necessary standards.
The Biologic API Contract Manufacturer market is highly competitive, with a number of established players. Some of the major companies in the market include Lonza, Boehringer Ingelheim, Patheon, and Catalent. Show Less Read more